Found: 70
Select item for more details and to access through your institution.
Management of refractory cirrhotic ascites: challenges and solutions.
- Published in:
- Hepatic Medicine: Evidence & Research, 2018, v. 10, p. 55, doi. 10.2147/HMER.S136578
- By:
- Publication type:
- Article
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9814, doi. 10.3390/ijms23179814
- By:
- Publication type:
- Article
Association between Equol Production Status and Nonalcoholic Steatohepatitis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11904, doi. 10.3390/ijms222111904
- By:
- Publication type:
- Article
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6921, doi. 10.3390/ijms22136921
- By:
- Publication type:
- Article
Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5589, doi. 10.3390/ijms21155589
- By:
- Publication type:
- Article
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 2164, doi. 10.3390/ijms21062164
- By:
- Publication type:
- Article
Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan.
- Published in:
- In Vivo, 2023, v. 37, n. 3, p. 1226, doi. 10.21873/invivo.13199
- By:
- Publication type:
- Article
Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.
- Published in:
- In Vivo, 2022, v. 36, n. 3, p. 1477, doi. 10.21873/invivo.12854
- By:
- Publication type:
- Article
Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2465, doi. 10.3390/jcm10112465
- By:
- Publication type:
- Article
Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 629, doi. 10.3390/jcm10040629
- By:
- Publication type:
- Article
Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3510, doi. 10.3390/jcm9113510
- By:
- Publication type:
- Article
Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1635, doi. 10.3390/jcm9061635
- By:
- Publication type:
- Article
Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1467, doi. 10.3390/jcm9051467
- By:
- Publication type:
- Article
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 4, p. 145, doi. 10.3390/antibiotics9040145
- By:
- Publication type:
- Article
Zinc Supplementation and an Improved Quality of Life in Patients with Autoimmune Hepatitis.
- Published in:
- Internal Medicine, 2024, v. 63, n. 2, p. 145, doi. 10.2169/internalmedicine.1817-23
- By:
- Publication type:
- Article
Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia.
- Published in:
- Digestive Diseases, 2020, v. 38, n. 4, p. 329, doi. 10.1159/000504044
- By:
- Publication type:
- Article
Aspartate aminotransferase to platelet ratio index has utility as a biomarker of COVID‐19 severity in patients with nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2023, v. 53, n. 11, p. 1047, doi. 10.1111/hepr.13943
- By:
- Publication type:
- Article
Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 8, p. 713, doi. 10.1111/hepr.13904
- By:
- Publication type:
- Article
Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute‐on‐chronic liver failure development and prognosis in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 4, p. 390, doi. 10.1111/hepr.13743
- By:
- Publication type:
- Article
Effect of three or more treatments with lusutrombopag in patients with cirrhotic thrombocytopenia: A retrospective single‐center study.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1101, doi. 10.1111/hepr.13536
- By:
- Publication type:
- Article
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 7, p. 840, doi. 10.1111/hepr.13509
- By:
- Publication type:
- Article
Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 10, p. 1147, doi. 10.1111/hepr.13385
- By:
- Publication type:
- Article
Blocking development of liver fibrosis augments hepatic progenitor cell‐derived liver regeneration in a mouse chronic liver injury model.
- Published in:
- Hepatology Research, 2019, v. 49, n. 9, p. 1034, doi. 10.1111/hepr.13351
- By:
- Publication type:
- Article
Identification of clinical risk factors for histological progression of primary biliary cholangitis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 9, p. 1015, doi. 10.1111/hepr.13355
- By:
- Publication type:
- Article
Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 3, p. 284, doi. 10.1111/hepr.13281
- By:
- Publication type:
- Article
Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 2, p. 232, doi. 10.1111/hepr.13249
- By:
- Publication type:
- Article
Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis.
- Published in:
- Hepatology Research, 2018, v. 48, n. 3, p. E52, doi. 10.1111/hepr.12926
- By:
- Publication type:
- Article
Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.
- Published in:
- Hepatology Research, 2017, v. 47, n. 12, p. 1317, doi. 10.1111/hepr.12860
- By:
- Publication type:
- Article
Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.
- Published in:
- Hepatology Research, 2017, v. 47, n. 9, p. 854, doi. 10.1111/hepr.12826
- By:
- Publication type:
- Article
Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis.
- Published in:
- Hepatology Research, 2017, v. 47, n. 3, p. E178, doi. 10.1111/hepr.12746
- By:
- Publication type:
- Article
ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score.
- Published in:
- Hepatology Research, 2012, v. 42, n. 5, p. 459, doi. 10.1111/j.1872-034X.2011.00950.x
- By:
- Publication type:
- Article
Gastric granular cell tumor in a youth excised by endoscopic submucosal dissection : A case report and literature review.
- Published in:
- Acta Gastro-Enterologica Belgica, 2017, v. 80, n. 2, p. 317
- By:
- Publication type:
- Article
Gastric adenocarcinoma of fundic gland type (chief cell predominant type) with unique endoscopic appearance curatively treated by endoscopic submucosal resection.
- Published in:
- Acta Gastro-Enterologica Belgica, 2015, v. 78, n. 3, p. 336
- By:
- Publication type:
- Article
Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4463, doi. 10.3390/jcm12134463
- By:
- Publication type:
- Article
ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1835, doi. 10.3390/jcm11071835
- By:
- Publication type:
- Article
Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa ® and VIVA ® Systems.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 2, p. 434, doi. 10.3390/jcm11020434
- By:
- Publication type:
- Article
The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 4838, doi. 10.3390/jcm10214838
- By:
- Publication type:
- Article
Laser-cut-type versus braided-type covered self-expandable metallic stents for distal biliary obstruction caused by pancreatic carcinoma: a retrospective comparative cohort study.
- Published in:
- Clinical Endoscopy, 2022, v. 55, n. 3, p. 434, doi. 10.5946/ce.2021.161
- By:
- Publication type:
- Article
Efficacy of Underwater Endoscopic Mucosal Resection for Superficial Non-Ampullary Duodenal Epithelial Tumor.
- Published in:
- Clinical Endoscopy, 2021, v. 54, n. 3, p. 371, doi. 10.5946/ce.2020.147
- By:
- Publication type:
- Article
Rifaximin enhances the L-carnitine-mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut-liver-muscle axis.
- Published in:
- International Journal of Molecular Medicine, 2022, v. 50, n. 2, p. N.PAG, doi. 10.3892/ijmm.2022.5157
- By:
- Publication type:
- Article
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis.
- Published in:
- Microorganisms, 2020, v. 8, n. 6, p. 925, doi. 10.3390/microorganisms8060925
- By:
- Publication type:
- Article
Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 4, p. 381, doi. 10.3350/cmh.2019.0037
- By:
- Publication type:
- Article
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 65, doi. 10.3350/cmh.2018.0070
- By:
- Publication type:
- Article
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection.
- Published in:
- Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 65, doi. 10.3350/cmh.2018.0070
- By:
- Publication type:
- Article
Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 8, p. 4001, doi. 10.1111/jcmm.16363
- By:
- Publication type:
- Article
Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascites.
- Published in:
- Portal Hypertension & Cirrhosis, 2023, v. 2, n. 3, p. 109, doi. 10.1002/poh2.55
- By:
- Publication type:
- Article
Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B.
- Published in:
- Experimental & Therapeutic Medicine, 2020, v. 20, n. 2, p. 985, doi. 10.3892/etm.2020.8798
- By:
- Publication type:
- Article
Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection.
- Published in:
- Experimental & Therapeutic Medicine, 2018, v. 16, n. 3, p. 2743, doi. 10.3892/etm.2018.6481
- By:
- Publication type:
- Article
Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis.
- Published in:
- Biomedical Reports, 2020, v. 13, n. 6, p. 1, doi. 10.3892/br.2020.1372
- By:
- Publication type:
- Article
Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure.
- Published in:
- Biomedical Reports, 2017, v. 7, n. 3, p. 277, doi. 10.3892/br.2017.945
- By:
- Publication type:
- Article